GlassScriptPhysician profile
Shariff Dunlap
NPI 1699063925
$9,179.35
in general payments reported to CMS, 2019-2025
63 companies · $2,187 in 2025
The $2,187 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,011 · 2020: $311 · 2021: $70.16 · 2022: $701 · 2023: $1,815 · 2024: $2,085 · 2025: $2,187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,086.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,086.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,093.96 | 2021-2025 | Ubrelvy, Qulipta, Botox |
| Novartis Pharmaceuticals Corporation | $740.05 | 2019-2025 | |
| Lilly USA, LLC | $579.39 | 2019-2025 | Emgality, Reyvow, Kisunla |
| Teva Pharmaceuticals USA, INC. | $521.07 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Biogen, INC. | $515.18 | 2019-2025 | Vumerity, Tysabri, Avonex |
| Pfizer INC. | $479.34 | 2023-2025 | |
| Lundbeck LLC | $431.00 | 2019-2025 | Vyepti |
| Amgen INC. | $424.19 | 2019-2025 | Uplizna |
| Eisai INC. | $268.34 | 2022-2025 | |
| Grifols USA, LLC | $228.38 | 2019-2025 | Gamunex-C |
| Genentech USA, INC. | $227.97 | 2023-2025 | Ocrevus, Ocrevus Zunovo |
| Csl Behring | $216.38 | 2019-2025 | Hizentra |
| Jazz Pharmaceuticals INC. | $211.56 | 2023-2025 | Epidiolex |
| Neurelis, INC. | $204.41 | 2023-2025 | Valtoco |
| Celgene Corporation | $202.63 | 2022-2025 | Zeposia |
Show all 63 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shariff Dunlap listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.